Maridea Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Maridea Wealth Management's PFE Position: Q1 2026 in Review
Maridea Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 8,450 shares — an estimated $210K sold.
Maridea Wealth Management first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $724K in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Maridea Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Maridea Wealth Management sold 8,450 Pfizer shares in Q1 2026, an estimated $210K.
- Maridea Wealth Management first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
- Maridea Wealth Management's Pfizer position peaked at $724K in Q4 2024.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Maridea Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.